期刊文献+

LIN28B调控miRNAs维持MCF-7肿瘤干细胞的干性特征 被引量:3

LIN28B maintains the stemness of cancer stem cells in MCF-7 cell line via regulating miRNAs
下载PDF
导出
摘要 目的研究LIN28B对人乳腺癌细胞(MCF-7)肿瘤干细胞的干性状态维持的作用机制。方法在MCF-7细胞中瞬时过表达LIN28B,用q PCR和Western blot检测干性相关基因SOX2、NAONG、c-Myc和OCT4的表达;用流式细胞仪检测CD44high/CD24low细胞亚群的比例;利用体外成球培养检测肿瘤干细胞自我更新的能力,通过RNA第二代测序技术检测在LIN28B过表达后MCF-7细胞中miRNAs的表达差异,通过转染差异表达的miRNA,检测其对MCF-7细胞肿瘤干细胞比例和体外成球能力的影响。结果转染p-CMV6-LIN28B后能明显提高LIN28B的mRNA和蛋白水平(P<0.001);过表达LIN28B后MCF-7细胞中SOX2、NANOG和OCT4在RNA和蛋白水平表达都明显增高(P<0.05);CD44high/CD24low细胞比例由1.71%上升至11.60%(P<0.05);体外成球培养发现成球细胞数量明显增多(P<0.01);通过RNA测序发现有16个miRNAs在LIN28B过表达后差异表达倍数在2倍以上且P<0.05,LIN28B过表达后miR-92b-5p表达显著上调(P<0.01);转染miR-92b-5p mimic后MCF-7细胞的CD44high/CD24low细胞比例由1.14%上升至3.59%(P<0.05),体外成球能力明显增强(P<0.01)。结论 LIN28B能维持MCF-7肿瘤干细胞的干性状态,其作用机制可能是通过miRNAs的表达来实现的。 Objective To investigate the effect of LIN28B on maintaining the stemness of cancer stem cells in MCF-7 breast cancer cell line.Methods LIN28B was instantaneously overexpressed in MCF-7 cells (LIN28B-MCF-7).The expression of stemness related genes in both mRNA and protein level was detected by either qPCR or Western blot;the proportion of CD44high/CD241ow cells was quantitated by flow cytometry;tumorsphere forming ability was analyzed by in vitro experiment;the differential expression of miRNAs either in LIN28B overexpression cells or wild type cells was detected by miRNA-sequencing or real-time PCR.The ability of tumorspheres forming was detected after transfecting miRNA mimics.Results The expression of LIN28B significantly increased in MCF-7 cells that transfected p-CMV6-LIN28B (P < 0.001).The expression of either mRNA and protein of SOX2,NANOG,c-Myc and OCT4 were up-regulated (P < 0.05);the proportion of CD44high/CD24low cells increased from 1.71% to 11.60% (P < 0.05);the number of tumorspheres was significantly improved (P < 0.01) in LIN28B-MCF-7 cells;16 miRNAs of differential expression were found by miRNA-sequencing in LIN28B-MCF-7 cells comparing to wild type cells.The proportion of CD44high/CD24low cells was increased from 1.14% to 3.59% (P < 0.05),and the ability of tumorsphere forming was significantly increased in MCF-7 cells after transfecting miR-92b-5p mimic (P < 0.01).Conclusions LIN28B keeps the stemness of cancer stem cells by regulating miRNAs in MCF-7 cell line.
出处 《基础医学与临床》 CSCD 2015年第6期754-760,共7页 Basic and Clinical Medicine
基金 国家重点基础研究发展计划(2013CB967202)
关键词 LIN28B 肿瘤干细胞 肿瘤相关干性 MIRNAS LIN28B cancer stem cells tumor associated stemness miRNAs
  • 相关文献

参考文献13

  • 1Basak SK, Veena MS, Oh S, et al. The CD44hi' tumori- genic subsets in lung cancer biospecimens are enriched for low miR-34a expression [ J]. PLoS One, 2013, 8: e73195, doi: 10. 1371/annotation/que8db84-5d44-4agc- pbS0-47c9d68820ea. 被引量:1
  • 2Nguyen LH, Robinton DA, Seligson MT, et al. Lin28b is sufficient to drive liver cancer and necessary for its mainte- nance in routine models [J]. Cancer Cell, 2014, 26: 248- 261. 被引量:1
  • 3Jiang X, Huang H, IA Z, et al. Blockade of miR-150 mat- uration by MLL-fusion/MYC/LIN-28 is required for MLL- associated leukemia [ J ], Cancer Cell, 2012, 22: 524-535. 被引量:1
  • 4Wang L, Wang J. MieroRNA-mediated breast cancer me- tastasis: from primary site to distant organs [ J ]. Onco- gene, 2012, 31: 2499-2511. 被引量:1
  • 5King CE, Wang L, Winograd R, et al. LIN28B fosters co- lon cancer migration, invasion and transformation through let-7 dependent and in-dependent mechanisms [J]. Onco- gene, 2011, 30: 4185-4193. 被引量:1
  • 6Shyh-Chang N, Zhu H, Yvanka de Soysa T, et ai, In28 enhances tissue repair by reprogramming cellular metabo- lism [J]. Cell, 2013, 155: 778-792. 被引量:1
  • 7Shyh-Chang N, Daley GQ. Lin28: primal regulator of growth and metabolism in stem cells [ J ], Cell Stem Cell, 2013, 12: 395-406. 被引量:1
  • 8Chou MY, Hu FW, Yu CH, et al. SOX2 expression in- volvement in the oncogenicity and radiochemoresistance of oral cancer stem cells [J]. Oral Oncol, 2015, 51 : 31-39. 被引量:1
  • 9Lin H, Sun LH, Han W, et al. Knockdown of OCT4 sup- presses the growth and invasion of pancreatic cancer cells through inhibition AKT pathway [ J]. Mol Med Rep, 2014, 10 : 1335-1342. 被引量:1
  • 10Bu, P, Chen KY, Chen JI-I, et al. A microRNA miR- 34a-regulated bimodal switch targets Notch in colon cancer stem cells [J]. Cell Stem Cell, 2013, 12: 602-615. 被引量:1

同被引文献37

  • 1李治,黄韬,贺艳丽,张家华,张景辉,田元.乳腺癌干细胞逃逸化疗机制的研究[J].中华实验外科杂志,2007,24(1):20-21. 被引量:20
  • 2盛佳钰,陈红风.乳腺癌的上皮间质转化与多药耐药[C]//第十三届全国中医及中西医结合乳腺病学术年会论文集2013:160-164. 被引量:1
  • 3蒋国勤,袁年勇,何建刚.白杨素逆转乳腺癌干细胞的耐药性实验研究[C]//江苏省第四次乳腺甲状腺内分泌外科学术会议论文集.2009:50-53. 被引量:1
  • 4Hardt O, Wild S, Oerlecke I, et al. Highly sensitive profiling of CD44+/CD24- breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathway. Cancer Lett. 2012;325(2): 165-174. 被引量:1
  • 5Singh JK, Simoes BM, Clarke RB, et al. Targeting IL-8 signalling to inhibit breast cancer stem cell activity. Expert Opin Ther Targets. 2013;17(11):1235-1241. 被引量:1
  • 6RodyA, Karn T, Holtrich U, et al. "Stem cell like" breasl cancers-a model for the identification of new prognostic/predictive markers in endocrine responsive breast cancer exemplified by Plexin B1. Eur J Obstet Gynecol Reprod Biol. 2008; 139(1 ): 11-15. 被引量:1
  • 7Buckley NE, Nic An tSaoir CB, Blayney JK, et al. BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers. Nucleic Acids Res. 2013;41 (18):8601-8614. 被引量:1
  • 8Tchokouaha RF, Alexi X, Chosson E, et al. Erymildbraedin A and B, two novel cytotoxic dimethylpyrano-isoflavones from the stem bark of Erythrina mildbraedii: evaluation of their activity toward endocrine cancer cells. J Enzyme Inhib Med Chem. 2010;25(2):228-233. 被引量:1
  • 9Tanei T, Morimoto K, Shimazu K, et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin Cancer Res. 2009; 15(12):4234-4241. 被引量:1
  • 10Colleoni M, Sun Z, Martinelli G, et al. The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up. Ann Oncol. 2009; 20(8): 1344-1351. 被引量:1

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部